A longitudinal analysis of the effects of a DRD4 polymorphism on marijuana use

Psychiatry Research

Volumn 210, Issue 1, 2013, Pages 247-255

  Vaske, Jamie ^a   Boisvert, Danielle ^b   Wright, John Paul ^c   Beaver, Kevin M ^d  

^a WESTERN CAROLINA UNIVERSITY   (United States)

^b SAM HOUSTON STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Add Health; DRD4; Marijuana use; Trajectory

Indexed keywords

DOPAMINE 4 RECEPTOR;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CANNABIS SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DECISION MAKING; DOPAMINERGIC SYSTEM; ENDOPHENOTYPE; ENTROPY; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; ILLNESS TRAJECTORY; LIMBIC SYSTEM; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROBABILITY; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION;

ADD HEALTH; DRD4; MARIJUANA USE; TRAJECTORY;

ADOLESCENT; ADULT; AGE FACTORS; DECISION MAKING; DEPRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LONGITUDINAL STUDIES; MALE; MARIJUANA SMOKING; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, DOPAMINE D4; SELF REPORT; YOUNG ADULT;

EID: 84885857705     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2013.04.022     Document Type: Article

References (66)

1. Add Health Biomarker Team Biomarkers in Wave III of the Add Health Study 2003, Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
2. Adinoff B. Neurobiological processes in drug reward and addiction. Harvard Review of Psychiatry 2004, 12:305-320.
3. Adkins D.E., Daw J.K., McClay J.L., van den Oord E.J.C.G. The influence of five monoamine genes on trajectories of depressive symptoms across adolescence and young adulthood. Development and Psychopathology 2012, 24:267-285.
4. Agrawal A., Lynskey M.T. Candidate genes for cannabis use disorders: findings, challenges and directions. Addiction 2009, 104:518-532.
5. Arcos-Burgos M., Castellanos F.X., Konecki D., Lopera F., Pineda D., Palacio J.D., Rapoport J.L., Berg K., Bailey-Wilson J., Muenke M. Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate. Molecular Psychiatry 2004, 9:252-259.
6. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H.M. Modulation of intracellular cyclic AMP levels of by different human dopamine D4 receptor variants. Journal of Neurochemistry 1995, 65:1157-1165.
7. Beach S.R.H., Brody G.H., Lei M.K., Philibert R.A. Differential susceptibility to parenting among African American youths: testing the DRD4 hypothesis. Journal of Family Psychology 2010, 24:513-521.
8. Beaulieu J.M., Gainetdinov R.R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews 2011, 63:182-217.
9. Bechara A., Damasio A.R. The somatic marker hypothesis: a neural theory of economic decision. Games and Economic Behavior 2005, 52:336-372.
10. Block R.I., Ghoneim M.M. Effects of chronic marijuana use on human cognition. Psychopharmacology (Berl) 1993, 110:219-228.
11. Boardman J.D., Finch B.K., Ellison C.G., Williams D.R., Jackson J.S. Neighborhood disadvantage, stress, and drug use among adults. Journal of Health and Social Behavior 2001, 42:151-165.
12. Brook J.S., Brook D.W., Gordon A.S., Whiteman M., Cohen P. The psychosocial etiology of adolescent drug use: a family interactional approach. Genetic, Social, and General Psychology Monographs 1990, 116:111-267.
13. Brook J.S., Whiteman M., Cohen P., Shapiro J., Balka E. Longitudinally predicting late adolescent and young adult drug use: childhood and adolescent precursors. Journal of the American Academy of Child & Adolescent Psychiatry 1995, 34:1230-1236.
14. Brook J.S., Zhang C., Brook D.W. Developmental trajectories of marijuana use from adolescence to adulthood: personal predictors. Archives of Pediatrics & Adolescent Medicine 2010, 165:55-60.
15. Brown T.A. Confirmatory Factor Analysis for Applied Research 2006, Guilford Press, New York.
16. Chan D. The conceptualization and analysis of change over time: an integrative approach incorporating longitudinal mean and covariance structures analysis (LMACS) and multiple indicator latent growth modeling (MLGM). Organizational Research Methods 1998, 1:421-483.
17. Chang F.M., Kidd J.R., Livak K.J., Pakstis A.J., Kidd K.K. The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Human Genetics 1996, 98:91-101.
18. Cheer J.F., Wassum K.M., Heien M.L.A.V., Phillips P.E.M., Wightman R.M. Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. The Journal of Neuroscience 2004, 24:4393-4400.
19. Chen K., Kandel D.B. The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 1995, 85:41-47.
20. Cohen C., Perrault G., Voltz C., Steinberg R., Soubrié P. SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behavioural Pharmacology 2002, 13:451-463.
21. Comings D.E., Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Progress in Brain Research 2000, 126:325-341.
22. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Blake H., Dietz George, Saucier Gerard, MacMurray J.P. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clinical Genetics 2000, 57:178-196.
23. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Chen C, Koh P., Farwell K., Blake H., Dietz G., MacMurray J.P., Lesieur H.R., Rugle L.J., Rosenthal R.J. The additive effect of neurotransmitter genes in pathological gambling. Clinical Genetics 2001, 60:107-116.
24. Creemers H.E., Harakeh Z., Dick D.M., Meyers J., Vollebergh W.A.M, Ormel J., Verhulst F.C., Huizink A.C. DRD2 and DRD4 in relation to regular alcohol and cannabis use among adolescents: does parenting modify the impact of genetic vulnerability? The TRAILS study. Drug & Alcohol Dependence 2011, 115:35-42.
25. Filbey F.M., Schacht J.P., Myers U.S., Chavez R.S., Hutchison K.E. Marijuana craving in the brain. Proceedings of the National Academy of Sciences 2009, 106:13016-13021.
26. Forbes E.E., Brown S.M., Kimak M., Ferrell R.E., Manuck S.B., Hariri A.R. Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Molecular Psychiatry 2009, 14:60-70.
27. Franke P., Wang T., Möthen M.M., Knapp M., Neith H., Lichtermann D., Meyer zur Cappellen K., Sander T., Propping P., Maier W. Susceptibility for alcoholism: DRD4 exon III polymorphism: a case-control and a family-based association approach. Addiction Biology 2000, 5:289-295.
28. Franken I.H.A. Drug craving and addiction: integrating psychological and neuropsychopharmacological approaches. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2003, 27:563-579.
29. Fu Q., Heath A.C., Bucholz K.K., Nelson E., Goldberg J., Lyons M.J., True W.R., Jacob T., Tsuang M.T., Eisen S.A. Shared genetic risk of major depression, alcohol dependence, and marijuana dependence: contribution of antisocial personality disorder in men. Archives of General Psychiatry 2002, 59:1125-1132.
30. Gelernter J., Kranzler H., Coccaro E., Siever L., New A., Mulgrew C.L. D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality disorder, and control studies. American Journal of Human Genetics 1997, 61:1144-1152.
31. 1 receptors. European Journal of Pharmacology 1998, 341:39-44.
32. Goldman M., Szucs-Reed R.P., Jagannathan K., Ehrman R.N., Wang Z., Li Y., Suh J.J., Kampman K., O'brien C.P., Childress A.R., Franklin T.R. Reward-related brain response and craving correlates of marijuana cue exposure: a preliminary study in treatment-seeking marijuana-dependent subjects. Journal of Addiction Medicine 2013, 7:8-16.
33. Green A., Burgess E., Dawson R., Zimmet S.V., Strous R.D. Alcohol and cannabis use in schizophrenia: effects of clozapine versus resperidone. Schizophrenia Research 2003, 60:81-85.
34. Guo G., Tillman K.H. Trajectories of depressive symptoms, dopamine D2 and D4 receptors, family socioeconomic status and social support in adolescence and young adulthood. Psychiatric Genetics 2009, 19:14-26.
35. Harris, K. M., Florey, F., Tabor, J., Bearman, P. S., Jones, J., Udry, J. R., 2003. The National Longitudinal Study of Adolescent Health: Research design [www document] URL: http://www.Cpc.Unc.edu/projects/addhealth/design.
36. Hutchison K.E., Wooden A., Swift R.M., Smolen A., McGeary J., Adler L., Paris L. Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology 2003, 28:1882-1888.
37. Hutchison K.E., Ray L., Sandman E., Rutter M.C., Peters A., Davidson D., Swift R. The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology 2005, 31:1310-1317.
38. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annual Reviews of Neuroscience 2006, 29:565-598.
39. Jessor R. Predicting time of onset of marijuana use: a developmental study of high school youth. Journal of Consulting and Clinical Psychology 1976, 44:125-134.
40. Johnston L.D., O'Malley P.M., Bachman J.G., Schulenberg J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings 2011, 2010. Institute for Social Research, University of Michigan, Ann Arbor.
41. Kendler K.S., Schmitt E., Aggen S.H., Prescott C.A. Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Archives of General Psychiatry 2008, 65:674-682.
42. Larsen H., van der Zwaluw C.S., Overbeek G., Granic I., Franke B., Engels R.C.M.E A variable number of tandem repeats polymorphism in the dopamine D4 receptor gene affects social adaptation of alcohol use: investigation of a gene-environment interaction. Psychological Science 2010, 21:1064-1068.
43. Laursen B., Hoff E. Person-centered and variable-centered approaches to longitudinal data. Merrill-Palmer Quarterly 2006, 52:377-389.
44. Maes H.H., Woodard C.E., Murrelle L., Meyer J.M., Silberg J.L., Hewitt J.K., Rutter M., Simonoff E., Pickles A., Carbonneau R., Neale M., Eaves L.J. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia twin study of adolescent behavioral development. Journal of Studies on Alcohol 1999, 60:293-305.
45. McGeary J.E. The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review. Pharmacology, Biochemistry, and Behavior 2009, 93:222-229.
46. McGeary J.E., Esposito-Smythers C., Spirito A., Monti P.M. Association of the dopamine D4 receptor gene VNTR polymorphism with drug use in adolescent psychiatric inpatients. Pharmacology, Biochemistry, and Behavior 2007, 86:401-406.
47. McGue M., Elkins I., Iacono W.G. Genetic and environmental influences on adolescent substance use and abuse. American Journal of Medical Genetics 2000, 96:671-677.
48. Miles D.R., van den Bree M.B., Gupman A.E., Newlin D.B., Glantz M.D., Pickens R.W. A twin study on sensation seeking, risk taking behavior, and marijuana use. Drug & Alcohol Dependence 2001, 62:57-68.
49. Missale C., Nash S.R., Robinson S.W., Jaber M., Caron M.G. Dopamine receptors: from structure to function. Physiological Reviews 1998, 78:189-225.
50. Moffitt T.E. Adolescence-limited and life course persistent antisocial behavior: a developmental taxonomy. Psychological Review 1993, 100:674-701.
51. Moore B.A., Augustson E.M., Moser R.P., Budney A.J. Respiratory effects of marijuana and tobacco use in a U.S. sample. Journal of General Internal Medicine 2005, 20:33-37.
52. Muthén B., Muthén L.K. Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes. Alcoholism: Clinical & Experimental Research 2000, 24:882-891.
53. Nagin D.S. Group-Based Modeling of Development 2005, Harvard University, Cambridge, MA.
54. Newcomb M.D., Bentler P.M. Substance use and ethnicity: differential impact of peer and adult models. Journal of Psychology 1986, 120:83-95.
55. Noble E.P., Ozkaragoz T.Z., Ritchie T.L., Zhang X., Belin T.R., Sparkles R.S. D2 and D4 dopamine receptor polymorphisms and personality. American Journal of Medical Genetics 1998, 81:257-267.
56. Olsson, C. A., Moyzis, R. K., Williamson, E., Ellis, J. E., Parkinson-Bates, M., Patton, G. C., Dwyer, T., Romaniuk, H., Moore, E.E. Gene-environment interaction in problematic substance use: interaction between DRD4 and insecure attachments. Addiction Biology, in press. http://dx.doi.org/10.1111/j.1369-1600.2011.00413.x.
57. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977, 1:385-401.
58. Schultz W., Dayan P., Montague P.R. A neural substrate of prediction and reward. Science 1997, 275:1593-1599.
59. Schwartz R.H., Gruenewald P.J., Klitzner M., Fedio P. Short-term memory impairment in cannabis-dependent adolescents. American Journal of Diseases of Children 1989, 143:1214-1219.
60. Shedler J., Block J. Adolescent drug use and psychological health: a longitudinal inquiry. American Journal of Psychology 1990, 45:612-630.
61. 4 receptors in rat forebrain. International Journal of Developmental Neuroscience 2000, 18:29-37.
62. Van Tol H.H.M., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B, Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 1992, 358:149-152.
63. Vaske J. Genes and Abuse as Causes of Offending 2011, LFB Scholarly, El Paso, TX.
64. Ward J.T., Stogner J., Gibson C.L., Akers R.L. A new trick for an old dog: applying developmental trajectories to inform drug use progression. Journal of Drug Issues 2010, 40:755-782.
65. Windle M., Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Development and Psychopathology 2004, 16:1007-1027.
66. Young S.E., Rhee S.H., Stallings M.C., Corley R.P., Hewitt J.K. Genetic and environmental vulnerabilities underlying adolescent substance use and problem use: general or specific?. Behavioral Genetics 2006, 36:603-615.